As of 2025-05-04, the EV/EBITDA ratio of Genertec Universal Medical Group Co Ltd (2666.HK) is 18.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 2666.HK's latest enterprise value is 62,664.30 mil HKD. 2666.HK's TTM EBITDA according to its financial statements is 3,438.18 mil HKD. Dividing these 2 quantities gives us the above 2666.HK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 18.1x | 15.4x |
| Forward P/E multiples | 7.7x - 8.9x | 8.0x |
| Fair Price | (8.54) - 7.17 | (2.90) |
| Upside | -265.6% - 39.0% | -156.2% |
| Date | EV/EBITDA |
| 2025-05-02 | 35.08 |
| 2025-04-30 | 34.96 |
| 2025-04-29 | 34.20 |
| 2025-04-28 | 34.08 |
| 2025-04-25 | 34.08 |
| 2025-04-24 | 34.12 |
| 2025-04-23 | 34.24 |
| 2025-04-22 | 34.28 |
| 2025-04-17 | 34.40 |
| 2025-04-16 | 34.52 |
| 2025-04-15 | 34.64 |
| 2025-04-14 | 34.96 |
| 2025-04-11 | 34.56 |
| 2025-04-10 | 34.12 |
| 2025-04-09 | 33.72 |
| 2025-04-08 | 33.56 |
| 2025-04-07 | 33.32 |
| 2025-04-03 | 35.72 |
| 2025-04-02 | 35.64 |
| 2025-04-01 | 35.52 |
| 2025-03-31 | 35.36 |
| 2025-03-28 | 35.40 |
| 2025-03-27 | 35.52 |
| 2025-03-26 | 35.28 |
| 2025-03-25 | 35.56 |
| 2025-03-24 | 35.80 |
| 2025-03-21 | 35.56 |
| 2025-03-20 | 35.76 |
| 2025-03-19 | 36.00 |
| 2025-03-18 | 35.64 |
| 2025-03-17 | 35.36 |
| 2025-03-14 | 35.24 |
| 2025-03-13 | 35.00 |
| 2025-03-12 | 34.84 |
| 2025-03-11 | 34.76 |
| 2025-03-10 | 34.88 |
| 2025-03-07 | 34.76 |
| 2025-03-06 | 34.80 |
| 2025-03-05 | 34.68 |
| 2025-03-04 | 34.40 |
| 2025-03-03 | 34.56 |
| 2025-02-28 | 34.52 |
| 2025-02-27 | 35.36 |
| 2025-02-26 | 35.36 |
| 2025-02-25 | 35.00 |
| 2025-02-24 | 35.36 |
| 2025-02-21 | 35.24 |
| 2025-02-20 | 34.96 |
| 2025-02-19 | 34.52 |
| 2025-02-18 | 34.52 |